Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseHematopoietic Stem CellsStem CellsTransplantation, AutologousWhole-Body IrradiationHematopoietic Stem Cell TransplantationBone and BonesAnemia, AplasticTransplantation ConditioningLeukemiaTransplantation ChimeraHematopoiesisBone Marrow PurgingGraft SurvivalLiver TransplantationCell DifferentiationTissue DonorsBone Marrow DiseasesColony-Forming Units AssayBusulfanMice, Inbred C57BLStem Cell TransplantationHistocompatibility TestingCyclophosphamideHistocompatibilityBone Marrow ExaminationAntigens, CD34Transplantation, IsogeneicRadiation ChimeraCells, CulturedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow NeoplasmsLeukemia, Myeloid, AcuteTime FactorsKidney TransplantationCombined Modality TherapyRecurrenceCell LineageHematologic NeoplasmsTreatment OutcomeLeukemia, MyeloidRemission InductionFlow CytometryPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressive AgentsGraft RejectionGranulocyte Colony-Stimulating FactorHepatic Veno-Occlusive DiseaseBone RemodelingLymphoma, Non-HodgkinGraft vs Host ReactionTransplantation ImmunologyLymphocyte DepletionT-LymphocytesAcute DiseaseImmunosuppressionChimeraCell SeparationMyelodysplastic SyndromesLeukocyte TransfusionGranulocytesSevere Combined ImmunodeficiencyHeart TransplantationHematopoietic Stem Cell MobilizationCell ProliferationMice, KnockoutSurvival AnalysisHLA AntigensHematologic DiseasesSpleenMice, TransgenicRetrospective StudiesPancytopeniaMyeloid Progenitor CellsMice, Inbred BALB CCell CountAntigens, CDLeukocyte CountAntineoplastic Combined Chemotherapy ProtocolsCyclosporineLymphocyte TransfusionActuarial AnalysisLung TransplantationCarmustineStromal CellsBone DensityImmunophenotypingCytarabineBlood CellsNuclear FamilyMultiple MyelomaNeural Stem CellsFollow-Up StudiesCell DivisionCell TransplantationSurvival Rate